Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy

In the US, the most significant morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) is embolic stroke, with 90% of thrombus originating from the left atrial appendage (LAA). Anticoagulation is the preferred treatment for the prevention of stroke in NVAF patients, but clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Slaughter, Mark S., Monreal, Gretel, Koenig, Steven C., Giridharan, Guruprasad A., Tompkins, Landon H., Jimenez, Jorge H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219146/
https://www.ncbi.nlm.nih.gov/pubmed/34157041
http://dx.doi.org/10.1371/journal.pone.0253299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219146/
https://www.ncbi.nlm.nih.gov/pubmed/34157041
http://dx.doi.org/10.1371/journal.pone.0253299

Ejemplares similares